Dissecting the contribution of thrombin exosite i in the recognition of thrombin binding aptamer

FEBS Journal

Volumn 280, Issue 24, 2013, Pages 6581-6588

  Pica, Andrea ^a   Russo Krauss, Irene ^a   Merlino, Antonello ^a,b   Nagatoishi, Satoru ^c   Sugimoto, Naoki ^d   Sica, Filomena ^a,b,e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF TOKYO   (Japan)

^d KONAN UNIVERSITY   (Japan)

^e Interuniversity Consortium of Structural and Systems Biology   (Italy)

Author keywords

biosensors; G quadruplex; human thrombin; protein nucleic acid complex; thrombin binding aptamer; thrombosis

Indexed keywords

APTAMER; GUANINE QUADRUPLEX; THROMBIN; THROMBIN BINDING APTAMER; THROMBIN BINDING APTAMER DELTA T12; THROMBIN BINDING APTAMER DELTA T3; THROMBIN EXOSITE I; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CRYSTALLOGRAPHY; HUMAN; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; STRUCTURE ANALYSIS;

BIOSENSORS; G-QUADRUPLEX; HUMAN THROMBIN; PROTEIN-NUCLEIC ACID COMPLEX; THROMBIN BINDING APTAMER; THROMBOSIS;

APTAMERS, NUCLEOTIDE; CIRCULAR DICHROISM; CRYSTALLIZATION; G-QUADRUPLEXES; HUMANS; MUTATION; THROMBIN;

EID: 84889679159     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12561     Document Type: Article

References (40)

1. Janin J, Rodier F, Chakrabarti P, &, Bahadur RP, (2007) Macromolecular recognition in the Protein Data Bank. Acta Crystallogr D 63, 1-8.
2. Hong H, Goel S, Zhang Y, &, Cai W, (2011) Molecular imaging with nucleic acid aptamers. Curr Med Chem 18, 4195-4205.
3. Keefe AD, Pai S, &, Ellington A, (2010) Aptamers as therapeutics. Nat Rev Drug Discov 9, 537-550.
4. Hermann T, &, Patel DJ, (2000) Adaptive recognition by nucleic acid aptamers. Science 287, 820-825.
5. Tan W, Wang H, Chen Y, Zhang X, Zhu H, Yang C, Yang R, &, Liu C, (2011) Molecular aptamers for drug delivery. Trends Biotechnol 29, 634-640.
6. Musumeci D, &, Montesarchio D, (2012) Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer. Pharmacol Ther 136, 202-215.
7. Dhar S, Gu FX, Langer R, Farokhzad OC, &, Lippard SJ, (2008) Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci USA 105, 17356-17361.
8. Bunka DH, Platonova O, &, Stockley PG, (2010) Development of aptamer therapeutics. Curr Opin Pharmacol 10, 557-562.
9. Bompiani KM, Woodruff RS, Becker RC, Nimjee SM, &, Sullenger BA, (2012) Antidote control of aptamer therapeutics: the road to a safer class of drug agents. Curr Pharm Biotechnol 13, 1924-1934.
10. Avino A, Fabrega C, Tintore M, &, Eritja R, (2012) Thrombin binding aptamer, more than a simple aptamer: chemically modified derivatives and biomedical applications. Curr Pharm Des 18, 2036-2047.
11. Huntington JA, (2005) Molecular recognition mechanisms of thrombin. J Thromb Haemost 3, 1861-1872.
12. Fenton JW 2nd, (1981) Thrombin specificity. Ann N Y Acad Sci 370, 468-495.
13. Adams TE, &, Huntington JA, (2006) Thrombin-cofactor interactions: structural insights into regulatory mechanisms. Arterioscler Thromb Vasc Biol 26, 1738-1745.
14. Welsby IJ, Monroe DM, Lawson JH, &, Hoffmann M, (2005) Recombinant activated factor VII and the anaesthetist. Anaesthesia 60, 1203-1212.
15. Bock LC, Griffin LC, Latham JA, Vermaas EH, &, Toole JJ, (1992) Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355, 564-566.
16. Russo Krauss I, Pica A, Merlino A, Mazzarella L, &, Sica F, (2013) Duplex-quadruplex motifs in a peculiar structural organization cooperatively contribute to thrombin binding of a DNA aptamer. Acta Crystallogr D 69, doi: 10.1107/S0907444913022269.
17. Russo Krauss I, Merlino A, Randazzo A, Novellino E, Mazzarella L, &, Sica F, (2012) High-resolution structures of two complexes between thrombin and thrombin-binding aptamer shed light on the role of cations in the aptamer inhibitory activity. Nucleic Acids Res 40, 8119-8128.
18. Macaya RF, Schultze P, Smith FW, Roe JA, &, Feigon J, (1993) Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. Proc Natl Acad Sci USA 90, 3745-3749.
19. Burge S, Parkinson GN, Hazel P, Todd AK, &, Neidle S, (2006) Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res 34, 5402-5415.
20. Borbone N, Bucci M, Oliviero G, Morelli E, Amato J, D'Atri V, D'Errico S, Vellecco V, Cirino G, Piccialli G, et al,. (2012) Investigating the role of T7 and T12 residues on the biological properties of thrombin-binding aptamer: enhancement of anticoagulant activity by a single nucleobase modification. J Med Chem 55, 10716-10728.
21. Sagi J, (2013) G-quadruplexes incorporating modified constituents: a review. J Biomol Struct Dyn in press. doi: 10.1080/07391102.2013.775074.
22. Bunka DH, &, Stockley PG, (2006) Aptamers come of age-at last. Nat Rev Microbiol 4, 588-596.
23. Russo Krauss I, Merlino A, Giancola C, Randazzo A, Mazzarella L, &, Sica F, (2011) Thrombin-aptamer recognition: a revealed ambiguity. Nucleic Acids Res 39, 7858-7867.
24. Nagatoishi S, &, Sugimoto N, (2012) Interaction of water with the G-quadruplex loop contributes to the binding energy of G-quadruplex to protein. Mol BioSyst 8, 2766-2770.
25. Figueiredo AC, Clement CC, Zakia S, Gingold J, Philipp M, &, Pereira PJ, (2012) Rational design and characterization of D-Phe-Pro-D-Arg-derived direct thrombin inhibitors. PLoS ONE 7, e34354.
26. Lima LM, Becker CF, Giesel GM, Marques AF, Cargnelutti MT, de Oliveira Neto M, Monteiro RQ, Verli H, &, Polikarpov I, (2009) Structural and thermodynamic analysis of thrombin:suramin interaction in solution and crystal phases. Biochim Biophys Acta 1794, 873-881.
27. Davis JT, (2004) G-quartets 40 years later: from 5′-GMP to molecular biology and supramolecular chemistry. Angew Chem Int Ed Engl 43, 668-698.
28. Bonifacio L, Church FC, &, Jarstfer MB, (2008) Effect of locked-nucleic acid on a biologically active G-quadruplex. A structure-activity relationship of the thrombin aptamer. Int J Mol Sci 9, 422-433.
29. Heckel A, &, Mayer G, (2005) Light regulation of aptamer activity: an anti-thrombin aptamer with caged thymidine nucleobases. J Am Chem Soc 127, 822-823.
30. Nagatoishi S, Isono N, Tsumoto K, &, Sugimoto N, (2011) Loop residues of thrombin-binding DNA aptamer impact G-quadruplex stability and thrombin binding. Biochimie 93, 1231-1238.
31. Padmanabhan K, &, Tulinsky A, (1996) An ambiguous structure of a DNA 15-mer thrombin complex. Acta Crystallogr D 52, 272-282.
32. Russo Krauss I, Merlino A, Randazzo A, Mazzarella L, &, Sica F, (2010) Crystallization and preliminary X-ray analysis of the complex of human alpha-thrombin with a modified thrombin-binding aptamer. Acta Crystallogr F 66, 961-963.
33. Russo Krauss I, Merlino A, Vergara A, &, Sica F, (2013) An overview of biological macromolecule crystallization. Int J Mol Sci 14, 11643-11691.
34. Otwinowski Z, &, Minor W, (1997) Processing of X-ray diffraction data collected in oscillation mode. In Methods in Enzymology (, Carter CW Jr, ed.), pp. 307-326. Academic Press, New York.
35. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, &, Read RJ, (2007) Phaser crystallographic software. J Appl Crystallogr 40, 658-674.
36. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, et al,. (1998) Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D 54, 905-921.
37. Vagin AA, Steiner RA, Lebedev AA, Potterton L, McNicholas S, Long F, &, Murshudov GN, (2004) REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr D 60, 2184-2195.
38. Emsley P, Lohkamp B, Scott WG, &, Cowtan K, (2010) Features and development of Coot. Acta Crystallogr D 66, 486-501.
39. Laskowski RA, Moss DS, &, Thornton JM, (1993) Main-chain bond lengths and bond angles in protein structures. J Mol Biol 231, 1049-1067.
40. Schrodinger L, (2010) The PyMOL Molecular Graphics System, Version 1.3. Schrödinger, LLC.